Sequoia Financial Advisors LLC Has $4.05 Million Stake in Danaher Corporation (NYSE:DHR)

Sequoia Financial Advisors LLC lowered its position in Danaher Corporation (NYSE:DHR - Free Report) by 11.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,735 shares of the conglomerate's stock after selling 2,584 shares during the period. Sequoia Financial Advisors LLC's holdings in Danaher were worth $4,046,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of DHR. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares in the last quarter. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $27,000. Rialto Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter valued at about $34,000. Hurley Capital LLC acquired a new position in Danaher during the 4th quarter worth about $34,000. Finally, Dunhill Financial LLC lifted its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Robert W. Baird dropped their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Argus lowered their price target on shares of Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Jefferies Financial Group reduced their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Barclays reiterated an "overweight" rating and issued a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Finally, Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a research report on Friday, March 14th. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $248.61.

Danaher Trading Down 1.6%

NYSE:DHR traded down $3.26 during trading hours on Friday, hitting $198.20. The stock had a trading volume of 5,619,393 shares, compared to its average volume of 3,505,541. The business's 50 day moving average is $194.84 and its 200-day moving average is $208.33. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The company has a market cap of $141.84 billion, a price-to-earnings ratio of 38.48, a P/E/G ratio of 2.79 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's dividend payout ratio is currently 24.85%.

Insiders Place Their Bets

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.